What should be the primary target of "treat to target" in psoriatic arthritis?

類似資料

• What should be the primary target of ‘treat to target’ in PsA?
  著者:: Coates, L, 等
  出版事項: (2018)
• Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
  著者:: Coates, L, 等
  出版事項: (2022)
• Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
  著者:: Coates, L, 等
  出版事項: (2019)
• Sustained very low disease activity and remission in psoriatic arthritis patients
  著者:: Lubrano, E, 等
  出版事項: (2019)
• Secukinumab for ankylosing spondylitis and psoriatic arthritis
  著者:: Lubrano E, 等
  出版事項: (2016-10-01)